The AJ Brown Decline Nobody Wants to Talk About

The Numbers Don't Lie

Two straight years of declining production. Six regular season games missed in the last two seasons. Drops in the biggest playoff game of the year — including the one that could have changed the outcome against San Francisco.

AJ Brown is still a good player. Nobody's arguing otherwise. But "good" and "$32 million good" are two very different conversations, and Philadelphia needs to have the second one honestly.

YouTube videoWatch on YouTube ↗

The Scouting Report Warned Us

Before the NFL Draft, Lance Zierlein's scouting profile on Brown included one sentence that now reads like prophecy: "Drops appear when focus declines."

That's not a hot take from a frustrated fan. That's a professional evaluation from before Brown ever played an NFL snap. And it maps perfectly to what happened in the playoff loss to San Francisco — a game where the Eagles combined for four drops on third down, their most in 20 years.

Was it a bad game? Sure. Every great player has bad games. But the pattern — drops increasing as frustration builds, focus wandering when targets decrease — matches the pre-draft warning to an uncomfortable degree.

The Whole Offense Is Aging

Brown isn't the only Eagle whose best days might be behind him. Run through the entire offensive roster and the picture gets sobering fast.

Landon Dickerson? Both knees and both ankles injected with stem cells in Colombia. His best days are likely behind him. Lane Johnson? Turning 36 off a Lisfranc sprain. Still phenomenal when healthy, but Father Time is undefeated. Cam Jurgens got stem cell treatment on his back. Dallas Goedert is on a one-year deal for a reason.

The only offensive players clearly still ascending are Jalen Hurts and DeVonta Smith. That's it. The Eagles are closer to needing an offensive retool than at any point in the last four years.

The Trade Value Equation Is Changing

The Rams reportedly pulled out of AJ Brown trade discussions after preliminary medical research raised concerns about his degenerative knee — an issue that dates back to his time in Tennessee. That's eerily similar to Baltimore getting cold feet on Maxx Crosby.

If teams are getting scared off by the medical, that affects trade value. The longer this drags on, the fewer suitors there are. Right now it's New England and nobody else. The Chiefs, Chargers, and Bills have all moved on.

What Eagles Fans Need to Accept

AJ Brown was brilliant here. Four years averaging around 1,250 yards per season. A Super Bowl ring. Moments that will live forever in Philadelphia sports history.

But the cost-benefit analysis is changing. At 29 with a $32 million cap hit, a troublesome knee, and a desire to play somewhere else, the smart move might be taking whatever New England offers and reinvesting in the future. A conditional second that turns into a first — like the Carson Wentz deal — might be the best outcome for everyone.